Catalyst

Slingshot members are tracking this event:

Phase 1 Results of Akcea Therapeutics'(AKCA) AKCEA-TTR-LRx Presented at the Heart Failure Society of America Annual Meeting

Source Link:
https://ir.ionispharma.com/news-releases/news-release-details/positive-phase-1-results-akcea-ttr-lrx-presented-heart-failure

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AKCA
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 16, 2019
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Ttr Amyloidosis
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.